<DOC>
	<DOC>NCT00234819</DOC>
	<brief_summary>The purpose of this study is to determine whether bazedoxifene/conjugated estrogens combinations are effective in the treatment of moderate to severe vasomotor symptoms associated with menopause.</brief_summary>
	<brief_title>Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause</brief_title>
	<detailed_description />
	<mesh_term>Estrogens, Conjugated (USP)</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Generally healthy, postmenopausal women, aged 40 to 64, with last natural menstrual period completed at lease 6 months ago Intact uterus Seeking treatment for hot flushes and experiencing 7 moderate to severe hot flushes per day or 50 per week History of active presence of thrombophlebitis, thrombosis, thromboembolic disorders History of active presence of stroke, TIA, heart attack or ischemic heart disease History of melanoma, breast or any gynecologic cancer at any time; history of any other cancer within the past 5 years</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Menopause</keyword>
</DOC>